BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 26071930)

  • 21. Successful treatment of axillary hyperhidrosis with very low doses of botulinum toxin B: a pilot study.
    Hecht MJ; Birklein F; Winterholler M
    Arch Dermatol Res; 2004 Feb; 295(8-9):318-9. PubMed ID: 14648075
    [No Abstract]   [Full Text] [Related]  

  • 22. Botulinum toxin treatment for a compensatory hyperhidrosis subsequent to an upper thoracic sympathectomy.
    Huh CH; Han KH; Seo KI; Eun HC
    J Dermatolog Treat; 2002 Jun; 13(2):91-3. PubMed ID: 12060509
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pitfalls and complication avoidance associated with transthoracic endoscopic sympathectomy for primary hyperhidrosis (analysis of 2200 cases).
    Lin TS; Wang NP; Huang LC
    Int J Surg Investig; 2001; 2(5):377-85. PubMed ID: 12678542
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of endoscopic thoracic sympathetic block on plantar hyperhidrosis.
    Neumayer C; Panhofer P; Zacherl J; Bischof G
    Arch Surg; 2005 Jul; 140(7):676-80; discussion 680. PubMed ID: 16027333
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Society of Thoracic Surgeons expert consensus for the surgical treatment of hyperhidrosis.
    Cerfolio RJ; De Campos JR; Bryant AS; Connery CP; Miller DL; DeCamp MM; McKenna RJ; Krasna MJ
    Ann Thorac Surg; 2011 May; 91(5):1642-8. PubMed ID: 21524489
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reconstituted and frozen botulinum toxin A is as effective and safe as fresh for treating axillary hyperhidrosis: A retrospective study.
    Shayesteh A; Boman A; Hawas E; Carlberg B
    PLoS One; 2023; 18(12):e0295393. PubMed ID: 38048338
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bilateral thoracoscopic sympathectomy: results and long-term follow-up.
    Jeganathan R; Jordan S; Jones M; Grant S; Diamond O; McManus K; Graham A; McGuigan J
    Interact Cardiovasc Thorac Surg; 2008 Feb; 7(1):67-70. PubMed ID: 17998304
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Botulinum toxin type A in the treatment of primary axillary hyperhidrosis: a 52-week multicenter double-blind, randomized, placebo-controlled study of efficacy and safety.
    Lowe NJ; Glaser DA; Eadie N; Daggett S; Kowalski JW; Lai PY;
    J Am Acad Dermatol; 2007 Apr; 56(4):604-11. PubMed ID: 17306417
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of axillary hyperhidrosis with botulinum toxin: a single surgeon's experience with 53 consecutive patients.
    Doft MA; Kasten JL; Ascherman JA
    Aesthetic Plast Surg; 2011 Dec; 35(6):1079-86. PubMed ID: 21559989
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A randomized trial of T3-T4 versus T4 sympathectomy for isolated axillary hyperhidrosis.
    Munia MA; Wolosker N; Kauffman P; de Campos JR; Puech-Leão P
    J Vasc Surg; 2007 Jan; 45(1):130-3. PubMed ID: 17210397
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evidence-based consensus development and reduction of rate of endoscopic thoracic sympathectomy: a national study.
    Chang CH; Yang SH; Hsieh BS; Chan KA
    Dermatol Surg; 2009 Dec; 35(12):1970-7. PubMed ID: 19708877
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Botulinum toxin in the treatment of focal hyperhidrosis].
    Schnider P; Moraru E; Kittler H; Voller B; Kranz G; Auff E
    Wien Klin Wochenschr; 2001; 113 Suppl 4():36-41. PubMed ID: 15506051
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of axillary hyperhidrosis with botulinum toxin type A reconstituted in lidocaine or in normal saline: a randomized, side-by-side, double-blind study.
    Vadoud-Seyedi J; Simonart T
    Br J Dermatol; 2007 May; 156(5):986-9. PubMed ID: 17286630
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparative study of thoracoscopic sympathicotomy versus local surgical treatment for axillary hyperhidrosis.
    Heidemann E; Licht PB
    Ann Thorac Surg; 2013 Jan; 95(1):264-8. PubMed ID: 23200232
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diode laser hair removal does not interfere with botulinum toxin A treatment against axillary hyperhidrosis.
    Paul A; Kranz G; Schindl A; Kranz GS; Auff E; Sycha T
    Lasers Surg Med; 2010 Mar; 42(3):211-4. PubMed ID: 20333738
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of botulinum toxin type A in the treatment of focal axillary hyperhidrosis.
    Absar MS; Onwudike M
    Dermatol Surg; 2008 Jun; 34(6):751-5. PubMed ID: 18318723
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quality of life before surgery is a predictive factor for satisfaction among patients undergoing sympathectomy to treat hyperhidrosis.
    Wolosker N; Yazbek G; de Campos JR; Munia MA; Kauffman P; Jatene FB; Puech-Leao P
    J Vasc Surg; 2010 May; 51(5):1190-4. PubMed ID: 20299178
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low-dose efficacy of botulinum toxin A for axillary hyperhidrosis: a randomized, side-by-side, open-label study.
    Heckmann M; Plewig G;
    Arch Dermatol; 2005 Oct; 141(10):1255-9. PubMed ID: 16230563
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Surgical approaches and techniques in the management of severe hyperhidrosis.
    Baumgartner FJ
    Thorac Surg Clin; 2008 May; 18(2):167-81. PubMed ID: 18557590
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predicting improvement after surgery for palmar hyperhidrosis.
    Koskinen LO; Blomstedt P; Sjöberg RL
    Acta Neurol Scand; 2012 Nov; 126(5):324-8. PubMed ID: 22324518
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.